Cancer and sickle cell disease patients are raising concerns over gaps in the Social Health Authority (SHA) healthcare financing system, warning that limitations in insurance coverage, delays in approvals and difficulties accessing specialised services are putting their lives at risk.
Cancer patients have reported difficulties accessing treatment after exhausting their allocated medical cover, with some forced to pay out of pocket for medication, scans and other essential services.
The concerns have also centred on delays in implementing enhanced oncology benefits and reimbursement challenges affecting healthcare providers.
The concerns come amid reports of cancer patients being stranded as hospitals struggle with SHA cover limitations and treatment authorisations, raising questions about the adequacy and implementation of the scheme.
Meanwhile, sickle cell patients are calling on the government to improve access to specialised care in public hospitals, citing delays in treatment and difficulties obtaining essential medication.
Although SHA has introduced coverage for specialised sickle cell procedures, including red blood cell exchange transfusions and apheresis platelets, patients say access to the promised benefits remains a challenge.
The procedures attract cover of KSh70,000 and KSh20,000 respectively, with each available up to three times per policy period.
Speaking to journalists in Nairobi, an umbrella organisation championing the fight against non-communicable diseases called for existing gaps in the health insurance system to be addressed, accusing some hospitals of being reluctant to facilitate treatment through SHA.
The patients are also appealing to members of the public to donate blood to help save the lives of people living with sickle cell disease, many of whom depend on regular transfusions and specialised medical interventions.
They want the Ministry of Health and SHA to strengthen implementation of the healthcare benefits, streamline approvals and ensure patients can access treatment without unnecessary delays or financial hardship.
The patients further want SHA to engage healthcare providers and patient representatives to resolve implementation challenges, warning that continued delays could worsen health outcomes and deepen inequalities in access to essential healthcare services.









